Critical Considerations for Related Substance and Impurity Testing

Abstract

Related substance and impurity testing is a fundamental component of pharmaceutical quality assurance, ensuring the safety, efficacy, and consistency of drug substances and drug products throughout their lifecycle. Impurities may originate from raw materials, manufacturing processes, degradation pathways, storage conditions, or interactions with packaging materials. Even trace levels of these unwanted components can significantly affect product quality, therapeutic performance, and patient safety, highlighting the necessity for robust analytical methodologies and comprehensive regulatory compliance. Advances in analytical science, together with increasingly stringent international guidelines, have transformed impurity profiling into a critical element of pharmaceutical development, process optimization, quality control, and post-marketing surveillance. This review summarizes the critical considerations involved in related substance and impurity testing, with emphasis on impurity classification, analytical method selection, method validation, and regulatory expectations. The article discusses various categories of impurities, including organic, inorganic, residual solvent, elemental, and degradation impurities, and outlines their potential sources and impact on pharmaceutical quality. Particular attention is given to the selection and optimization of stability-indicating analytical methods, primarily High-Performance Liquid Chromatography (HPLC), Ultra-Performance Liquid Chromatography (UPLC), gas chromatography (GC), capillary electrophoresis (CE), and hyphenated techniques such as liquid chromatography–mass spectrometry (LC–MS), which enable sensitive detection, accurate quantification, and structural characterization of impurities. Furthermore, the review highlights critical method validation parameters, including specificity, accuracy, precision, linearity, robustness, detection limit, quantitation limit, and system suitability, in accordance with internationally accepted regulatory recommendations.